• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与致病性人类冠状病毒相关的专利。

Patents Related to Pathogenic Human Coronaviruses.

作者信息

Dos Santos Michelli, Ferreira André V F, da Silva Jonatas O, Nogueira Laís M, Machado Juliana M, Francisco Mariana F C, da Paz Mariana C, Giunchetti Rodolfo C, Galdino Alexsandro S

机构信息

Laboratório de Biotecnologia de Microrganismos, Universidade Federal de São João Del-Rei, Sebastião Gonçalves Coelho, 400, 355901-296, Divinópolis, MG, Brazil.

Laboratório de Nano- Biotecnologia & Bioativos, Universidade Federal de São João Del-Rei, Sebastião Gonçalves Coelho, 400, 355901-296, Divinópolis, MG, Brazil.

出版信息

Recent Pat Biotechnol. 2021;15(1):12-24. doi: 10.2174/1872208315666210127085404.

DOI:10.2174/1872208315666210127085404
PMID:33504319
Abstract

BACKGROUND

Coronaviruses have caused outbreaks of respiratory disease since the beginning of the 21st century, representing a significant threat to public health. Together, the severe acute respiratory syndrome coronavirus (SARS-CoV), the respiratory syndrome coronavirus (MERS-CoV), and, more recently, the novel coronavirus (SARS-CoV-2) have caused a large number of deaths around the world. Thus, investments in research and the development of strategies aimed at diagnosing, treating, and preventing these infections are urgently needed.

OBJECTIVE

The objective of this study was to analyze the patents that address pathogenic coronaviruses in Google Patents databases in the last year (2019-2020).

METHODS

The search strategy was carried out in April 2020, based on the keywords "SARS", "SARS-CoV", "MERS", "MERS-CoV", "SARS-CoV-2" and "COVID-19. Out of the patents examined, 25 were selected for a short description in this study.

RESULTS

A total of 191 patents were analyzed, 149 of which were related to SARS-CoV, and 29 and 12 were related to MERS-CoV and SARS- CoV2, respectively. The patents addressed the issues of diagnosis, therapeutic agents, prevention and control, along with other applications.

CONCLUSION

Several promising strategies have been documented in intellectual property databases favoring the need for further studies on the pathogenesis and optimization of the diagnosis and therapeutic treatment for these emerging infections.

摘要

背景

自21世纪初以来,冠状病毒已引发呼吸道疾病疫情,对公众健康构成重大威胁。严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)以及最近的新型冠状病毒(SARS-CoV-2)共同在全球造成了大量死亡。因此,迫切需要投资于旨在诊断、治疗和预防这些感染的研究及策略开发。

目的

本研究的目的是分析去年(2019 - 2020年)谷歌专利数据库中涉及致病性冠状病毒的专利。

方法

检索策略于2020年4月实施,基于关键词“SARS”、“SARS-CoV”、“MERS”、“MERS-CoV”、“SARS-CoV-2”和“COVID-19”。在所审查的专利中,本研究挑选了25项进行简短描述。

结果

共分析了191项专利,其中149项与SARS-CoV相关,29项和12项分别与MERS-CoV和SARS-CoV-2相关。这些专利涉及诊断、治疗药物、预防和控制等问题以及其他应用。

结论

知识产权数据库中记录了几种有前景的策略,这支持了对这些新出现感染的发病机制以及诊断和治疗优化进行进一步研究的必要性。

相似文献

1
Patents Related to Pathogenic Human Coronaviruses.与致病性人类冠状病毒相关的专利。
Recent Pat Biotechnol. 2021;15(1):12-24. doi: 10.2174/1872208315666210127085404.
2
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
3
A Case Study: Analysis of Patents on Coronaviruses and Covid-19 for Technological Assessment and Future Research.案例研究:冠状病毒和 COVID-19 专利的技术评估与未来研究分析。
Curr Pharm Des. 2021;27(3):423-439. doi: 10.2174/1381612826666200720233947.
4
Recent Patents and Advances on Nanotechnologies against Coronavirus.近期冠状病毒纳米技术专利及进展
Recent Pat Nanotechnol. 2021;15(4):322-330. doi: 10.2174/1872210514666201110125536.
5
Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development.微针阵列递呈的重组冠状病毒疫苗:免疫原性和快速转化开发。
EBioMedicine. 2020 May;55:102743. doi: 10.1016/j.ebiom.2020.102743. Epub 2020 Apr 2.
6
Coronaviruses - a new old menace.冠状病毒——新的旧威胁。
Postepy Biochem. 2021 Jan 5;66(4):303-308. doi: 10.18388/pb.2020_357. Print 2020 Dec 31.
7
Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.来源于日本健康供体的正常人静脉注射免疫球蛋白对 SARS-CoV-1/2、MERS-CoV 以及人类冠状病毒 229E 和 OC43 的中和及结合活性。
Transfusion. 2021 Feb;61(2):356-360. doi: 10.1111/trf.16161. Epub 2020 Oct 26.
8
Coronavirus - A Crippling Affliction to Humans.冠状病毒——人类的致残性疾病。
Recent Pat Biotechnol. 2022 Aug 3;16(3):226-242. doi: 10.2174/1872208316666220404103033.
9
Comparative pathology, molecular pathogenicity, immunological features, and genetic characterization of three highly pathogenic human coronaviruses (MERS-CoV, SARS-CoV, and SARS-CoV-2).三种高致病性人类冠状病毒(中东呼吸综合征冠状病毒、严重急性呼吸综合征冠状病毒和新型冠状病毒)的比较病理学、分子发病机制、免疫学特征和遗传特征。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7162-7184. doi: 10.26355/eurrev_202111_27270.
10
Current diagnostic approaches to detect two important betacoronaviruses: Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).目前用于检测两种重要的贝塔冠状病毒的诊断方法:中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)。
Pathol Res Pract. 2021 Sep;225:153565. doi: 10.1016/j.prp.2021.153565. Epub 2021 Jul 24.

引用本文的文献

1
A Systematic Review and Meta-Analysis Comparing the Diagnostic Accuracy Tests of COVID-19.一项比较新冠病毒病诊断准确性测试的系统评价和荟萃分析
Diagnostics (Basel). 2023 Apr 26;13(9):1549. doi: 10.3390/diagnostics13091549.